Biosensors Market Size, Share, Opportunities, And Trends By Type (Electrochemical, Physical, Wearable, Thermal Detection, Others), By Application (Quality Control, Medical Diagnosis, Pesticide Detection, Drug Development, Others), By Industry Vertical (Food & Beverage, Medical & Healthcare, Pharmaceuticals, Agriculture, Others), And By Geography - Forecasts From 2025 To 2030

Description

Biosensors Market Size:

The biosensors market is expected to grow from USD 37.055 billion in 2025 to USD 65.917 billion in 2030, at a CAGR of 12.21%.

Biosensors are often utilized in the healthcare field for diagnosing and detecting different illnesses. This includes blood glucose monitoring, pregnancy monitoring, and cholesterol testing. Biosensors are key instruments for detecting cancer and diabetes. The rising prevalence of chronic illnesses, along with technology advancements, is propelling the global biosensors market forward. The World Health Organization (WHO) reports that the prevalence of chronic diseases is steadily growing. Furthermore, the implementation of novel technologies such as artificial intelligence and the internet of things is paving the way for the worldwide biosensors market to expand. As a consequence of the rising prevalence of such diseases, the global biosensors market is expanding. Additionally, biosensors have several end-user applications that have been lucrative for the market. For instance, according to Abbott Laboratories, the Libre Sense glucose sports biosensors were made available in Europe in September 2020. The gadget was built on the most modern CGM technology to help athletes better comprehend the link between blood glucose levels and sports performance.

Biosensors Market Drivers:

• The increasing use of biosensors in the healthcare segment will significantly influence the market’s growth

Biosensors can be used for involves monitoring blood glucose levels, pregnancy, and cholesterol levels. Biosensors are a significant tool for detecting cancer and diabetes. The need for biosensors is increasing due to a wide range of medical applications, an increasing diabetic population, a high demand for tiny diagnostic devices, and rapid technical improvements. Early and correct identification of sickness is critical for a positive disease prognosis and patient survival. In recent years, there has been a boom in demand for portable, low-cost devices with quick reaction times. Furthermore, because of the prevalence of chronic and lifestyle-related ailments, consumers are being recommended to use biosensors to identify pathogenic activity in the body on a regular basis, which is projected to drive up demand for biosensors. Biosensor applications are developing because of significant growth in the global old population and the advancement of nanotechnology, which is improving their availability and cost. Therefore, companies have launched biosensor products that have been profitable for the healthcare segment. In February 2019, IQ Group Global, for example, introduced the glucose saliva biosensor. This cutting-edge technology is one of the few non-invasive glucose saliva-based diabetes testing procedures that does not involve blood collection. The saliva-based glucose test is being created to help the world's 425 million diabetics.

• The launch of innovative products by companies has considerably contributed to the market’s revenue

Companies have launched several innovative products to enhance and develop the market segment. In addition to building market strategies, they have also collaborated with other companies to expand their market presence. For example, in August 2021, XPhyto Therapeutics Corp. successfully registered its first biosensor check in oral inflammation with German authorities in partnership with its partner and purchase target, 3a-diagnostics GmbH. When placed on the tongue, the thin film dissolves and the biosensor releases a bitter taste after 5 minutes in the case of oral inflammation. The biosensor functions as a quick test for high levels of various bacteria and viruses, determining if a doctor's visit and extra tests are necessary. Furthermore, Biosensor Corporation in December 2022, Nix produced a wearable hydration meter. A reusable Bluetooth-enabled pod, mono patches, and a mobile app comprise the Nix Hydration Biosensor. The sensor detects the amount and composition of sweat lost, allowing users to know how much fluid to refill and which electrolytes to target. The app delivers push notifications on when to drink during an activity and gives automatic recommendations.

Biosensors Market Geographical Outlook:

• North America accounts for a major share during the forecasted period

Due to the prevalence of developments made by the companies in this region along with the emergence of artificial intelligence, the market for this region is anticipated to surge in the upcoming years. For instance, in November 2022, a new Salvus LLC facility in Valdosta, Georgia, increased capacity for the engineering, development, testing, and manufacture of interferometric-based biosensors for detecting poultry pollutants. The optoelectronic biosensor has the potential to enhance the identification of diseases, viruses, and infections in both production and processing settings in the poultry sector. Furthermore, in March 2022, Interaxon Inc., a leading consumer neurotechnology and meditation company announced the release of their VR Software Development Kit (SDK), as well as an EEG headband designed to be compatible with all major VR head-mounted displays (HMDs), based on Interaxon's second-generation EEG meditation and sleep headband. Interaxon's goal with this launch is to facilitate strategic collaboration prospects for brain health advancements by using their award-winning biosensing technology in VR and AR applications.

Biosensors Market Key Developments:

• In March 2022, Novo Nordisk expanded its medication delivery relationship with MIT and Brigham and Women's Hospital (BWH). The partners want to work together on biosensors, bioelectronics, and stimuli-responsive supply networks, building on advances like the SOMA robotic pill. Novo Nordisk has licensed the technology and is striving to bring it to the clinic. After then, the Danish pharmaceutical company increased the scope of its relationship with MIT and BWH and prolonged it through 2026.

The biosensors market has been analyzed through the following segments:

By Type

• Electrochemical
• Physical
• Wearable
• Thermal Detection
• Others

By Application

• Quality Control
• Medical Diagnosis
• Pesticide Control
• Drug Development
• Others

By End-User

• Food & Beverage
• Medical & Healthcare
• Pharmaceutical
• Agriculture
• Others

By Geography

• North America
  • USA
  • Canada
  • Mexico
• South America
  • Brazil
  • Argentina
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Australia
  • Others

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. BIOSENSORS MARKET BY TYPE

5.1. Introduction

5.2. Electrochemical

5.3. Physical

5.4. Wearable

5.5. Thermal Detection

5.6. Others

6. BIOSENSORS MARKET BY APPLICATION

6.1. Introduction

6.2. Quality Control

6.3. Medical Diagnosis

6.4. Pesticide Control

6.5. Drug Development

6.6. Others

7. BIOSENSORS MARKET BY END-USER

7.1. Introduction

7.2. Food & Beverage

7.3. Medical & Healthcare

7.4. Pharmaceutical

7.5. Agriculture

7.6. Others

8. BIOSENSORS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. ByType

8.2.2. By Application

8.2.3. By End-User

8.2.4. By Country

8.2.4.1. USA

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Type

8.3.2. By Application

8.3.3. By End-User

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Type

8.4.2. By Application

8.4.3. By End-User

8.4.4. By Country

8.4.4.1. Germany

8.4.4.2. France

8.4.4.3. United Kingdom

8.4.4.4. Italy

8.4.4.5. Spain

8.4.4.6. Others

8.5. Middle East and Africa

8.5.1. By Type

8.5.2. By Application

8.5.3. By End-User

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.2. UAE

8.5.4.3. Israel

8.5.4.4. Others

8.6. Asia Pacific

8.6.1. By Type

8.6.2. By Application

8.6.3. By End-User

8.6.4. By Country

8.6.4.1. China

8.6.4.2. India

8.6.4.3. Japan

8.6.4.4. South Korea

8.6.4.5. Indonesia

8.6.4.6. Thailand

8.6.4.7. Taiwan

8.6.4.8. Australia

8.6.4.9. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Abott Laboratories

10.2. Bio-Rad Laboratories Inc.

10.3. Sartorius AG

10.4. Nix Biosensors

10.5. Universal Biosensors

10.6. Pinnacle Technology Inc.

10.7. Dexcom Inc.

10.8. Analog Devices, Inc.

10.9. STMicroelectronics

10.10. Malvern Panalytical Ltd (Spectris)

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Abott Laboratories

Bio-Rad Laboratories Inc.

Sartorius AG

Nix Biosensors

Universal Biosensors

Pinnacle Technology Inc.

Dexcom Inc.

Analog Devices, Inc.

STMicroelectronics

Malvern Panalytical Ltd (Spectris)

Related Reports